omnibrx 
Dealstreet

ALMT Legal advises SIDBI Venture Capital on its investment in OmniBRx Biotechnologies

₹30 crores was invested by SIDBI into OmniBRx.

Bar & Bench

SIDBI Venture Capital Limited (SVCL) has made an investment in OmniBRx Biotechnologies. OmniBRx has raised ₹30 crores in Series A funding round from Ubharte Sitaare Fund of SIDBI Venture Capital Limited.

ALMT Legal advised SIDBI Venture Capital Limited (SVCL) in this investment.

The transaction team consisted of by Statira Ranina (Partner), Sheetal Mishra (Senior Associate) and Shivani More (Associate).

OmniBRx Biotechnologies is a company involved in the business of developing and manufacturing single use bioreactors (SUBs) specifically for adherent cell culture, with applications in areas like vaccine manufacturing, viral vector production, cell and gene therapies and bio therapeutics.

The funding supports the company’s vision to expand their business in the overseas market and investment in building manufacturing facilities and production capabilities.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Karnataka withdraws compulsory arbitration clause from State tenders, contracts

Bombay High Court acquits Assistant Public Prosecutor, law clerk in 22-year-old bribery case

Committee being set up to examine Deepfake issue: Centre tells Delhi High Court

Amend Constitution to do away with reference to district courts as subordinate judiciary: Justice AS Oka

Principle of estoppel does not apply when error by court needs to be corrected: Kerala High Court

SCROLL FOR NEXT